VolitionRX Ltd. | Ownership
Companies that own VolitionRX Ltd.
Lagoda Investment Management LP
1,811,250
6.03%
-1,304,511
1.28%
08/31/2018
Knoll Capital Management LP
351,538
1.17%
0
0.71%
06/30/2018
The Vanguard Group, Inc.
291,452
0.97%
400
0%
06/30/2018
Bridgeway Capital Management, Inc.
199,400
0.66%
0
0.01%
06/30/2018
Geode Capital Management LLC
100,890
0.34%
0
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
84,200
0.28%
-20,000
0%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
65,003
0.22%
3
0%
06/30/2018
Northern Trust Investments, Inc.
38,032
0.13%
4,241
0%
06/30/2018
Oppenheimer & Co., Inc. (Wealth Management)
36,966
0.12%
36,966
0%
06/30/2018
Skylands Capital LLC
30,855
0.1%
-90,245
0.01%
06/30/2018
| Address |
1 Scotts Road
Singapore CE 228208
Singapore
|
|
Employees
|
- |
| Website |
http://www.volitionrx.com |
| Updated |
07/08/2019 |
| VolitionRX Ltd. is a multi-national life sciences company, which engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was founded on August 5, 2010 and is headquartered in Singapore. |
